An investment case for new TB vaccines

The World Health Organization (WHO) released a document summarizing the results of the WHO-commissioned full value proposition for new TB vaccines.

The assessment was commissioned to provide early evidence for national and global decision-makers involved in TB vaccine development and implementation, who include stakeholders involved in vaccine research, financing, regulation and policy-making, manufacturing, introduction and procurement. The goal is to accelerate development of effective vaccines against TB and their rapid introduction into countries.

Download the document here.

Source: World Health Organization